XGN Competitors & Alternatives
Compare Exagen Inc with similar stocks in the same industry
Diagnostics & Research
XGN
Main Stock$7.92
Tradestie Score
40
Market Cap
$241.60M
Revenue Growth
0.2%
Analyst Upside
+24.5%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$16.98
|
$1.13B | - | 40 | Compare |
|
CDNA
CareDx, Inc.
|
$48.61
|
$798.40M | 22.4 | 35 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$19.90
|
$719.31M | - | 53 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$34.20
|
$667.77M | - | 33 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$18.38
|
$612.76M | - | 44 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$3.83
|
$504.67M | - | 44 | Compare |
|
APYX
Apyx Medical Corporation Common Stock
|
$3.12
|
$81.31M | - | 59 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$26.63
|
$61.36M | - | 34 | Compare |
|
TELA
TELA Bio, Inc. Common Stock
|
$0.65
|
$59.42M | - | 49 | Compare |
|
VRCA
Verrica Pharmaceuticals Inc. Common Stock
|
$4.82
|
$41.94M | - | 45 | Compare |
More XGN Analysis
Data updated: Aug 22, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry